1. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
   Tatjana Sauerer et al, 2023, Molecular Cancer CrossRef
2. Bispecific anti-CD3×anti-CD155 antibody mediates T-cell immunotherapy in human haematologic malignancies
   Li Ma et al, 2023, Investigational New Drugs CrossRef
3. Role of Biomarkers in FLT3 AML
   null Nitika et al, 2022, Cancers CrossRef
4. Overcoming tumor resistance mechanisms in CAR-NK cell therapy
   Antonio Valeri et al, 2022, Frontiers in Immunology CrossRef
5. CD155 as an emerging target in tumor immunotherapy
   Jiang-Wan Wu et al, 2024, International Immunopharmacology CrossRef
6. Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death
   Zhenlong Li et al, 2024, Cell CrossRef
7. Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
   Xinyu Guo et al, 2023, Heliyon CrossRef
8. Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
   Yanyu Wang et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
9. The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia
   Asal Barshidi et al, 2024, Cell Communication and Signaling CrossRef